Semaglutide has emerged as a novel treatment for type 2 diabetes. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and suppressing glucagon https://neilwdof836883.csublogs.com/42897736/understanding-semaglutide-a-comprehensive-guide